Does ALEMTUZUMAB Cause Mucosal inflammation? 259 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 259 reports of Mucosal inflammation have been filed in association with ALEMTUZUMAB (Campath). This represents 1.8% of all adverse event reports for ALEMTUZUMAB.
259
Reports of Mucosal inflammation with ALEMTUZUMAB
1.8%
of all ALEMTUZUMAB reports
65
Deaths
64
Hospitalizations
How Dangerous Is Mucosal inflammation From ALEMTUZUMAB?
Of the 259 reports, 65 (25.1%) resulted in death, 64 (24.7%) required hospitalization, and 51 (19.7%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 259 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which ALEMTUZUMAB Alternatives Have Lower Mucosal inflammation Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET